Neuphoria Therapeutics Inc. (NEUP)
NASDAQ: NEUP · Real-Time Price · USD
4.540
-0.100 (-2.16%)
At close: Mar 5, 2026, 4:00 PM EST
4.530
-0.010 (-0.22%)
After-hours: Mar 5, 2026, 7:27 PM EST
Neuphoria Therapeutics Income Statement
Financials in millions USD. Fiscal year is July - June.
Millions USD. Fiscal year is Jul - Jun.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2020 - 2016 |
|---|---|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Jun '25 Jun 30, 2025 | Jun '24 Jun 30, 2024 | Jun '23 Jun 30, 2023 | Jun '22 Jun 30, 2022 | Jun '21 Jun 30, 2021 | 2020 - 2016 |
| Operating Revenue | 14.99 | 15.65 | - | - | 0.18 | - | Upgrade
|
| Other Revenue | - | - | - | - | 3.99 | 0.7 | Upgrade
|
| Revenue | 14.99 | 15.65 | - | - | 4.17 | 0.7 | Upgrade
|
| Revenue Growth (YoY) | 2161.41% | - | - | - | 499.60% | -66.32% | Upgrade
|
| Cost of Revenue | - | - | - | - | 11.02 | 4.32 | Upgrade
|
| Gross Profit | 14.99 | 15.65 | - | - | -6.85 | -3.62 | Upgrade
|
| Selling, General & Admin | 7.47 | 7.77 | 8.47 | 8.91 | 5.28 | 4.23 | Upgrade
|
| Research & Development | 9.38 | 8.71 | 9.32 | 12.65 | - | - | Upgrade
|
| Other Operating Expenses | - | - | - | - | -0 | -0.15 | Upgrade
|
| Operating Expenses | 16.85 | 16.48 | 17.8 | 21.56 | 5.27 | 4.08 | Upgrade
|
| Operating Income | -1.86 | -0.83 | -17.8 | -21.56 | -12.12 | -7.7 | Upgrade
|
| Interest Expense | - | - | - | - | -0.02 | -1.07 | Upgrade
|
| Interest & Investment Income | 0.41 | 0.17 | 0.22 | 0.32 | 0.01 | 0 | Upgrade
|
| Currency Exchange Gain (Loss) | -0.96 | -0.41 | -0.21 | 0.31 | 0.25 | 0.81 | Upgrade
|
| Other Non Operating Income (Expenses) | -2.67 | - | - | - | -2.59 | -1.22 | Upgrade
|
| EBT Excluding Unusual Items | -5.08 | -1.08 | -17.79 | -20.93 | -14.48 | -9.18 | Upgrade
|
| Merger & Restructuring Charges | -1.24 | - | - | - | - | - | Upgrade
|
| Gain (Loss) on Sale of Investments | 0.24 | 0.24 | 2.21 | -0.59 | - | - | Upgrade
|
| Gain (Loss) on Sale of Assets | - | - | - | - | -0 | -0.02 | Upgrade
|
| Other Unusual Items | - | - | - | - | -0.65 | 2.54 | Upgrade
|
| Pretax Income | -6.08 | -0.84 | -15.58 | -21.52 | -15.12 | -6.66 | Upgrade
|
| Income Tax Expense | -0.42 | -0.47 | -0.09 | -0.14 | -0.13 | -0.14 | Upgrade
|
| Earnings From Continuing Operations | -5.66 | -0.37 | -15.49 | -21.38 | -14.99 | -6.52 | Upgrade
|
| Net Income | -5.66 | -0.37 | -15.49 | -21.38 | -14.99 | -6.52 | Upgrade
|
| Net Income to Common | -5.66 | -0.37 | -15.49 | -21.38 | -14.99 | -6.52 | Upgrade
|
| Shares Outstanding (Basic) | 3 | 2 | 1 | 1,469 | 1,353 | 780 | Upgrade
|
| Shares Outstanding (Diluted) | 3 | 2 | 1 | 1,469 | 1,353 | 780 | Upgrade
|
| Shares Change (YoY) | 123.33% | 95.01% | -99.94% | 8.53% | 73.52% | 43.14% | Upgrade
|
| EPS (Basic) | -2.18 | -0.23 | -18.62 | -0.01 | -0.01 | -0.01 | Upgrade
|
| EPS (Diluted) | -2.18 | -0.23 | -18.62 | -0.01 | -0.01 | -0.01 | Upgrade
|
| Free Cash Flow | -2.36 | 0.08 | -14.68 | -14.64 | -14.99 | -5.65 | Upgrade
|
| Free Cash Flow Per Share | -0.91 | 0.05 | -17.64 | -0.01 | -0.01 | -0.01 | Upgrade
|
| Gross Margin | 100.00% | 100.00% | - | - | -164.21% | - | Upgrade
|
| Operating Margin | -12.43% | -5.30% | - | - | -290.62% | -1107.29% | Upgrade
|
| Profit Margin | -37.79% | -2.36% | - | - | -359.34% | -937.11% | Upgrade
|
| Free Cash Flow Margin | -15.76% | 0.49% | - | - | -359.30% | -812.46% | Upgrade
|
| EBITDA | -1.2 | -0.17 | -17.13 | -20.9 | -11.49 | -7 | Upgrade
|
| EBITDA Margin | -8.01% | -1.06% | - | - | -275.36% | - | Upgrade
|
| D&A For EBITDA | 0.66 | 0.66 | 0.66 | 0.66 | 0.64 | 0.7 | Upgrade
|
| EBIT | -1.86 | -0.83 | -17.8 | -21.56 | -12.12 | -7.7 | Upgrade
|
| EBIT Margin | -12.43% | -5.30% | - | - | -290.62% | - | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.